全文获取类型
收费全文 | 6226篇 |
免费 | 479篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 157篇 |
妇产科学 | 163篇 |
基础医学 | 859篇 |
口腔科学 | 147篇 |
临床医学 | 655篇 |
内科学 | 1265篇 |
皮肤病学 | 91篇 |
神经病学 | 549篇 |
特种医学 | 329篇 |
外科学 | 638篇 |
综合类 | 149篇 |
一般理论 | 4篇 |
预防医学 | 673篇 |
眼科学 | 223篇 |
药学 | 378篇 |
中国医学 | 13篇 |
肿瘤学 | 387篇 |
出版年
2021年 | 102篇 |
2020年 | 52篇 |
2019年 | 86篇 |
2018年 | 100篇 |
2017年 | 76篇 |
2016年 | 74篇 |
2015年 | 76篇 |
2014年 | 121篇 |
2013年 | 200篇 |
2012年 | 248篇 |
2011年 | 293篇 |
2010年 | 185篇 |
2009年 | 199篇 |
2008年 | 237篇 |
2007年 | 252篇 |
2006年 | 273篇 |
2005年 | 288篇 |
2004年 | 288篇 |
2003年 | 280篇 |
2002年 | 248篇 |
2001年 | 178篇 |
2000年 | 178篇 |
1999年 | 156篇 |
1998年 | 107篇 |
1997年 | 94篇 |
1996年 | 80篇 |
1995年 | 83篇 |
1994年 | 80篇 |
1993年 | 82篇 |
1992年 | 114篇 |
1991年 | 124篇 |
1990年 | 115篇 |
1989年 | 114篇 |
1988年 | 118篇 |
1987年 | 109篇 |
1986年 | 102篇 |
1985年 | 85篇 |
1984年 | 76篇 |
1983年 | 62篇 |
1982年 | 76篇 |
1981年 | 60篇 |
1980年 | 78篇 |
1979年 | 56篇 |
1978年 | 73篇 |
1977年 | 72篇 |
1976年 | 56篇 |
1974年 | 55篇 |
1973年 | 49篇 |
1972年 | 40篇 |
1971年 | 34篇 |
排序方式: 共有6738条查询结果,搜索用时 15 毫秒
51.
52.
53.
BACKGROUND: Inherited metabolic disorders (IMDs) are a heterogeneous group of genetic conditions mostly occurring in childhood. They are individually rare but collectively numerous, causing substantial morbidity and mortality. AIMS: To obtain up-to-date estimates of the birth prevalence of IMDs in an ethnically diverse British population and to compare these estimates with those of other published population-based studies. METHODS: Retrospective data from the West Midlands Regional Diagnostic Laboratory for Inherited Metabolic Disorders (Birmingham, UK) for the 5 years (1999-2003) were examined. The West Midlands population of 5.2 million is approximately 10% of the UK population. Approximately 11% of the population of the region is from black and ethnic minority groups compared with approximately 8% for the the UK. RESULTS: The overall birth prevalence was 1 in 784 live births (95% confidence interval (CI) 619 to 970), based on a total of 396 new cases. The most frequent diagnoses were mitochondrial disorders (1 in 4929; 95% CI 2776 to 8953), lysosomal storage disorders (1 in 5175; 95% CI 2874 to 9551), amino acid disorders excluding phenylketonuria (1 in 5354; 95% CI 2943 to 9990) and organic acid disorders (1 in 7962; 95% CI 3837 to 17 301). Most of the diagnoses (72%) were made by the age of 15 years and one-third by the age of 1 year. CONCLUSIONS: These results are similar to those of the comparison studies, although the overall birth prevalence is higher in this study. This is probably due to the effects of ethnicity and consanguinity and increasing ascertainment. This study provides useful epidemiological information for those planning and providing services for patients with IMDs, including newborn screening, in the UK and similar populations. 相似文献
54.
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. 总被引:13,自引:0,他引:13
Stephen Couban Michael Goodyear Margot Burnell Sean Dolan Parveen Wasi David Barnes Darlene Macleod Erica Burton Pantelis Andreou David R Anderson 《Journal of clinical oncology》2005,23(18):4063-4069
PURPOSE: In this multicenter, randomized, placebo-controlled clinical trial, we studied whether warfarin 1 mg daily reduces the incidence of symptomatic central venous catheter (CVC) -associated thrombosis in patients with cancer. PATIENTS AND METHODS: Two hundred fifty-five patients with cancer who required a CVC for at least 7 days were randomly assigned to receive warfarin 1 mg or placebo. RESULTS: There were 11 (4.3%) symptomatic CVC-associated thromboses among 255 patients, with no difference in the incidence of symptomatic CVC-associated thrombosis between patients taking warfarin 1 mg daily (six of 130 patients; 4.6%) and patients taking placebo (five of 125 patients; 4.0%; hazard ratio, 1.20; 95% CI, 0.37 to 3.94). Warfarin had no effect on CVC life span (84 days v 63 days in control and warfarin groups, respectively; 95% confidence limit, -16 to 55 days; P = .09), and it did not affect the number of premature CVC removals (23.2% v 25.4% in control and warfarin groups, respectively; 95% confidence limit of difference -8.34 to 12.71; P = .68) or the frequency of major bleeding episodes (2% v 0% in control and warfarin groups, respectively; P = .5, Fisher's exact test). CONCLUSION: Symptomatic CVC-associated thrombosis in patients with cancer, although significant, is less common than previously reported. In this study, the administration of warfarin 1 mg daily did not reduce the incidence of symptomatic CVC-associated thrombosis in patients with cancer. However, the low rate of symptomatic CVC-associated thrombosis means that a much larger trial is required to address this issue definitively. 相似文献
55.
56.
Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. 总被引:25,自引:0,他引:25
OBJECTIVE: We sought to determine morphologically when the maternal uterine circulation to the human placenta is established. STUDY DESIGN: We performed a histologic review of 12 early-pregnancy hysterectomy specimens contained within the Boyd Collection, ranging from 43 to 130 days' gestation. RESULTS: Before the eighth week of pregnancy, maternal arterial connections with the intervillous space are restricted to tortuous networks of intercellular spaces. Only after this period can direct channels be observed. Initially, these are of small caliber, but they become sizable and clearly delineated after 11 to 12 weeks. CONCLUSION: The maternal circulation to the placenta must be extremely sluggish before the eighth week of pregnancy but will be gradually established over the next few weeks. It is unlikely to be substantial until at least 12 weeks. The implication is that development of the human fetoplacental unit during most of the first trimester takes place in a low-oxygen environment. 相似文献
57.
Brian L Sprague Amy Trentham-Dietz Curtis J Hedman Jue Wang Jocelyn DC Hemming John M Hampton Diana SM Buist Erin J Aiello Bowles Gale S Sisney Elizabeth S Burnside 《Breast cancer research : BCR》2013,15(3):R45
Introduction
Humans are widely exposed to estrogenically active phthalates, parabens, and phenols, raising concerns about potential effects on breast tissue and breast cancer risk. We sought to determine the association of circulating serum levels of these chemicals (reflecting recent exposure) with mammographic breast density (a marker of breast cancer risk).Methods
We recruited postmenopausal women aged 55 to 70 years from mammography clinics in Madison, Wisconsin (N = 264). Subjects completed a questionnaire and provided a blood sample that was analyzed for mono-ethyl phthalate, mono-butyl phthalate, mono-benzyl phthalate, butyl paraben, propyl paraben, octylphenol, nonylphenol, and bisphenol A (BPA). Percentage breast density was measured from mammograms by using a computer-assisted thresholding method.Results
Serum BPA was positively associated with mammographic breast density after adjusting for age, body mass index, and other potentially confounding factors. Mean percentage density was 12.6% (95% confidence interval (CI), 11.4 to 14.0) among the 193 women with nondetectable BPA levels, 13.7% (95% CI, 10.7 to 17.1) among the 35 women with detectable levels below the median (<0.55 ng/ml), and 17.6% (95% CI, 14.1 to 21.5) among the 34 women with detectable levels above the median (>0.55 ng/ml; Ptrend = 0.01). Percentage breast density was also elevated (18.2%; 95% CI, 13.4 to 23.7) among the 18 women with serum mono-ethyl phthalate above the median detected level (>3.77 ng/ml) compared with women with nondetectable BPA levels (13.1%; 95% CI, 11.9 to 14.3; Ptrend = 0.07). No other chemicals demonstrated associations with percentage breast density.Conclusions
Postmenopausal women with high serum levels of BPA and mono-ethyl phthalate had elevated breast density. Further investigation of the impact of BPA and mono-ethyl phthalate on breast cancer risk by using repeated serum measurements or other markers of xenoestrogen exposure are needed. 相似文献58.
Isolation and structure elucidation of new and unusual saxitoxin analogues from mussels 总被引:1,自引:0,他引:1
Dell'Aversano C Walter JA Burton IW Stirling DJ Fattorusso E Quilliam MA 《Journal of natural products》2008,71(9):1518-1523
Chemical analyses of plankton and highly toxic mussel samples collected in eastern Canada during an intense bloom of the dinoflagellate Alexandrium tamarense established the presence of a complex mixture of paralytic shellfish poisoning (PSP) toxins. Application of a newly developed technique, hydrophilic interaction liquid chromatography-mass spectrometry, confirmed the identities of the known toxins and revealed the presence in the mussels of five saxitoxin analogues (M1-M5) that were not present in the plankton. Four of these compounds were isolated and their structures established by tandem mass spectrometry, 1D- and 2D-NMR spectroscopy, and chemical interconversion experiments. One of these was found to be 11beta-hydroxysaxitoxin (M2), while the other three were found to be new saxitoxin analogues, namely, 11beta-hydroxy-N-sulfocarbamoylsaxitoxin (M1), 11,11-dihydroxy-N-sulfocarbamoylsaxitoxin (M3), and 11,11-dihydroxysaxitoxin (M4). Compound M5 remains unidentified because of insufficient material for characterization. 相似文献
59.
60.